NCT01808378

Stem Cells Treatment for Bilateral Limbic Associated Keratopathy (HULPOFT)

Phase IIa Clinical Trial to Study the Feasability and Security of the Expanded Autologous Stem Cells (ASC) From Lipoaspirate in the Bilateral Limbic Associated Keratopathy Treatment

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 8 (estimated)
• Sponsor: Instituto de Investigación Hospital Universitario La Paz · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Evaluate the use of the autologous ASC for the treatment of bilateral limbic associated keratopathy

Detailed description

Intralesional use by inject of adipose derived stem cells

Conditions

• Keratopathy

Interventions

Type	Name	Description
DRUG	Expanded adipose-derived stem cells	Local injection of autologousadipose derived stem cells

Timeline

• Start date: 2013-02-01
• Primary completion: 2013-12-01
• Completion: 2014-12-01
• First posted: 2013-03-11
• Last updated: 2013-03-11

Locations

1 site across 1 country: Spain